| The Epidemiology and Pathophysiology of Kidney Disease in HFpEF With Obesity (NCT07052539) | University of Mississippi Medical Center | 2022-07-22 |
| A Clinical Study to Evaluate the Pharmacokinetics of Microdose Midazolam, Dabigatran, Pitavastatin, Atorvastatin and Rosuvastatin in Healthy Volunteers and Renal Impairment Patients (NCT05747768) | Peking University Third Hospital | 2022-07-15 |
| Therapeutic Drug Use for CKD Patients (NCT05818995) | Qianfoshan Hospital | 2022-07-01 |
| A Study to Learn How Well the Treatment Combination of Finerenone and Empagliflozin Works and How Safe it is Compared to Each Treatment Alone in Adult Participants With Long-term Kidney Disease (Chronic Kidney Disease) and Type 2 Diabetes (NCT05254002) | Bayer | 2022-06-23 |
| Pharmacokinetics and Safety of MB-102 (Relmapirazin) and the MediBeacon Transdermal GFR Measurement System in Evaluation of Kidney Function in Normal and Renal Compromised Subjects (NCT05425719) | MediBeacon | 2022-06-14 |
| A Study Called FINE-REAL to Learn More About the Use of the Drug Finerenone in a Routine Medical Care Setting (NCT05348733) | Bayer | 2022-06-13 |
| Anakinra vs Prednisone to Treat Gout Flare in Patients With Chronic Kidney Disease Stage 4/5 or Renal Transplantation (NCT04844814) | Assistance Publique - Hôpitaux de Paris | 2022-06-02 |
| Probiotic Supplements in Chronic Kidney Disease (NCT05359094) | Taichung Veterans General Hospital | 2022-06-01 |
| OPTIMISE-CKD Drug Utilization (NCT05932901) | AstraZeneca | 2022-05-04 |
| Research on Gut Microbiota and Metabolomics in Diabetic Kidney Disease (NCT06833541) | The First Affiliated Hospital of Hunan University of Traditional Chinese Medicine | 2022-04-18 |
| Forxiga CKD Japan Post-Marketing Surveillance (PMS) (NCT05306210) | AstraZeneca | 2022-04-12 |
| A Study to Learn More About How Well the Study Treatment Finerenone Works, How Safe it is, How it Moves Into, Through, and Out of the Body, and the Effects it Has on the Body When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker in Children With Chronic Kidney Disease and Proteinuria (NCT05196035) | Bayer | 2022-03-28 |
| A Randomised, Open-Label Study to Evaluate the Relative and Absolute Bioavailability of Cotadutide in Healthy Subjects (NCT05294458) | AstraZeneca | 2022-03-28 |
| Dapagliflozin Post Marketing Surveillance in HF and CKD (NCT05134701) | AstraZeneca | 2022-03-10 |
| Exploring the Impact of " ACP Board Game for Life" on Death Preparation and Anxiety in Patients With Stage 4 and 5 Chronic Kidney Diseases: A Pilot Study (NCT06046261) | National Cheng-Kung University Hospital | 2022-01-01 |
| A Real World, Multi-centric, Observational Registry Study of Chronic Kidney Diseases (NCT05188885) | Guangdong Provincial People's Hospital | 2021-12-27 |
| Comprehensive Kidney Function Assessment and Early Warning in Older Adults (NCT07765134) | Huashan Hospital | 2021-12-10 |
| Effects of Sulforaphane for Patients With Chronic Kidney Disease (NCT04608903) | Universidade Federal Fluminense | 2021-12-01 |
| A Study to Evaluate the ePidemiology of anEmia Associated With chroNic Kidney Disease in Patients in Primary Care Using The Stockholm CREAtinine Measurement (SCREAM) Register (NCT05015998) | Astellas Pharma Europe Ltd. | 2021-11-30 |
| A Research Study Looking Into Levels of the Medicine NNC0385-0434 in the Body and How Well it is Tolerated in Participants With Impaired Kidney Function Compared to Participants With Normal Kidney Function (NCT05094934) | Novo Nordisk A/S | 2021-11-09 |
| Evaluation of Clinical Pharmacy Services and Drug Use in Renal Impairment. (NCT07241494) | Istanbul University - Cerrahpasa | 2021-10-31 |
| Pharmacokinetic/Pharmacodynamic Parameters of NNG-DEPO (Stimus) With Aranesp® (Amgen) in Treatment of Anemia in CKD Patients on Dialysis (NCT05636891) | Nanogen Pharmaceutical Biotechnology Joint Stock Company | 2021-09-19 |
| A Study to Examine Past Estimated Glomerular Filtration Rate (eGFR) Slope as a Risk Marker for Rapid Kidney Function Decline in People With Chronic Kidney Disease (NCT04881448) | Boehringer Ingelheim | 2021-09-16 |
| Kidney Sodium Functional Imaging (NCT05014178) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2021-09-16 |
| ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and Inflammation (NCT05021835) | Novo Nordisk A/S | 2021-08-30 |
| An add-on Study to the FIGARO-DKD Study Called FIGARO-BM to Learn About the Link Between Biomarkers (Substances in the Blood Used as Indicators of Biological Processes, Disease Processes or Responses to Medication) and Finerenone in FIGARO-DKD Participants (NCT05013008) | Bayer | 2021-08-18 |
| A Study to Learn More About Chronic Kidney Disease (CKD) in Patients With Type 2 Diabetes Mellitus (T2DM) (NCT05004428) | Bayer | 2021-08-14 |
| Study to Collect Samples for MIST Analysis of Zibotentan and Bioavailability of Zibotentan and Dapagliflozin in Heatlhy Participants (NCT04991571) | AstraZeneca | 2021-07-29 |
| A Trial to Learn More About How BAY2327949 Works and How Safe it is in Patients Whose Kidneys Are Damaged Due to High Blood Sugar Levels or High Blood Pressures, and With a Further Disease of the Heart or the Blood Vessels. (NCT04661917) | Bayer | 2021-05-31 |
| Low Dose Continuous Furosemide Effect on Cardiac Surgery Patients With Kidney Dysfunction (NCT04919564) | National Cardiovascular Center Harapan Kita Hospital Indonesia | 2021-05-27 |
| Zibotentan and Dapagliflozin for the Treatment of CKD (ZENITH-CKD Trial) (NCT04724837) | AstraZeneca | 2021-04-28 |
| A Research Study to Find Out How Semaglutide Works in the Kidneys Compared to Placebo, in People With Type 2 Diabetes and Chronic Kidney Disease (the REMODEL Trial) (NCT04865770) | Novo Nordisk A/S | 2021-04-28 |
| A Study to Test the Effect of Different Doses of Avenciguat (BI 685509) on Kidney Function in People With Chronic Kidney Disease (NCT04736628) | Boehringer Ingelheim | 2021-04-27 |
| Concordance Between Central Blood PRessure dEvices In Nephrology Patients (NCT05963880) | Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal | 2021-04-26 |
| A Study in Healthy Subjects to Assess Drug Availability of 4 Different Formulations of Verinurad and Allopurinol (NCT04550234) | AstraZeneca | 2021-04-13 |
| GLUcose Transport and REnalPROtection in Chronic Kidney Disease (NCT05998837) | IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy | 2021-04-13 |
| Study of the Influence of Liver Function on Blood Concentrations of Runcaciguat in Participants With Different Degrees of Liver Impairment (NCT04820621) | Bayer | 2021-04-07 |
| Study of the Effect of SZC on Serum Potassium and Serum Bicarbonate in Patients With Hyperkalemia and Metabolic Acidosis Associated With Chronic Kidney Disease (NCT04727528) | AstraZeneca | 2021-03-22 |
| Efficacy of Diuretics in Kidney Disease (NCT04542304) | Stanford University | 2021-03-01 |
| The KidneyCARE (Community Access to Research Equity) Study (NCT05497518) | Tufts Medical Center | 2021-02-25 |
| Bicarbonate Administration and Cognitive Function in Midlife and Older Adults With CKD (NCT04600323) | University of Colorado, Denver | 2021-02-01 |
| Study to Assess Relative Bioavailability and Safety of AZD5718 in Healthy Volunteers (NCT04734275) | AstraZeneca | 2021-02-01 |
| Efficacy, Safety and Tolerability of AZD9977 and Dapagliflozin in Participants With Heart Failure and Chronic Kidney Disease (NCT04595370) | AstraZeneca | 2021-01-26 |
| Mechanisms of EPO-induced Hypertension (NCT03810911) | VA Office of Research and Development | 2021-01-04 |
| Home-Based Exercise to Treat Decreased Physical Function in Patients With Varying Levels of Kidney Function (NCT04745169) | Baylor College of Medicine | 2020-12-21 |
| Replication of the DAPA-CKD (Chronic Kidney Disease) Trial in Healthcare Claims Data (NCT04882813) | Brigham and Women's Hospital | 2020-12-13 |
| Study of Pharmacokinetics and Safety of Apraglutide in Participants With Normal and Impaired Kidney Function. (NCT04699032) | VectivBio AG | 2020-12-08 |
| Chocolate for Patients With Chronic Kidney Disease (NCT04600258) | Universidade Federal Fluminense | 2020-10-30 |
| Cancer and Blood Pressure Management, CARISMA Study (NCT04467021) | ECOG-ACRIN Cancer Research Group | 2020-10-29 |
| Trial of Pirfenidone to Prevent Progression in Chronic Kidney Disease (NCT04258397) | Veterans Medical Research Foundation | 2020-10-26 |
| Trial to Evaluate Reduction in Inflammation in Patients With Advanced Chronic Renal Disease Utilizing Antibody Mediated IL-6 Inhibition in Japan. (NCT04626505) | Novo Nordisk A/S | 2020-10-22 |
| A Study to Evaluate the Safety and Efficacy of AZD5718 in Participants With Proteinuric Chronic Kidney Disease (NCT04492722) | AstraZeneca | 2020-10-01 |
| Pharmacokinetics of Verinurad and Allopurinol in Combination With Cyclosporine and Rifampicin in Healthy Volunteers (NCT04532918) | AstraZeneca | 2020-09-10 |
| Study on the Safety of the Drug Runcaciguat and How Well it Works When Given at the Highest Dose as Tolerated by Individual Patient Whose Kidneys Are Not Working Properly and Suffering at the Same Time From High Blood Sugar and/or High Blood Pressure and a Disease of the Heart and the Blood Vessels. (NCT04507061) | Bayer | 2020-09-01 |
| Association of Diuretics With Change in Extracellular Volume, Natriuretic Peptides, Symptoms, and Cardiovascular Outcomes in CKD (NCT04192110) | VA Office of Research and Development | 2020-08-11 |
| Low Sirtuin-1 Levels Are Linked to Erythropoietin Resistance in Hemodialysis Patients. (NCT06877286) | Cuma Bulent Gul | 2020-08-01 |
| A Study to Evaluate the Safety and Pharmacokinetics With MEDI8367 Administered in Healthy Subjects, and in Subjects With Chronic Kidney Disease (NCT04365218) | AstraZeneca | 2020-07-22 |
| Genetic Testing to Understand and Address Renal Disease Disparities Across the United States (NCT04191824) | Duke University | 2020-07-10 |
| Chat-based Instant Messaging Support Health Education Program (NCT05665517) | National Taiwan Normal University | 2020-04-13 |
| Low Protein Renal Formula as Meal Replacement in Predialysis CKD Patients (NCT05330663) | Taichung Veterans General Hospital | 2020-04-08 |
| Trial to Evaluate and Assess the Effect of Comprehensive Pre-ESKD Education on Home Dialysis Use in Veterans (NCT04064086) | VA Office of Research and Development | 2020-03-25 |
| Darbepoetin Alfa Once Monthly Dosing Schedule Maintains Hemoglobin Concentration Comparable to Every 2 Weeks Dosing Schedule in Advanced Chronic Kidney Disease Patients Not on Dialysis: A Multicenter, Phase 4 Study (NCT07025460) | Gangnam Severance Hospital | 2019-12-19 |
| A Study in People With Normal Kidney Function and People With Reduced Kidney Function to Test How BI 764198 is Processed in the Body (NCT04176536) | Boehringer Ingelheim | 2019-12-10 |
| Patient-Derived Stem Cell Therapy for Diabetic Kidney Disease (NCT03840343) | Mayo Clinic | 2019-10-23 |
| Severe Sepsis in Children - IMPRESS-C (NCT02598674) | University of Florida | 2019-10-01 |
| The Effects of Renal Function and Atrial Fibrillation on Lipoproteins and Clot Structure/Function (NCT04043026) | University of Liverpool | 2019-09-26 |
| Low-protein Formula Supplements in Chronic Kidney Disease (NCT05318014) | Taichung Veterans General Hospital | 2019-09-25 |
| A Study on Patients With Chronic Kidney Disease (CKD) to Assess Treatment Experience and Patterns, Effect of the Treatment, Patient Outcomes and Patient Quality of Life (NCT04034992) | AstraZeneca | 2019-09-11 |
| A Study of RBT-1 in Healthy Volunteers and Subjects With Stage 3/4 Chronic Kidney Disease (NCT03893799) | Renibus Therapeutics, Inc. | 2019-08-27 |
| A Study of a Renal Autologous Cell Therapy (REACT) in Patients With Chronic Kidney Disease (CKD) From Congenital Anomalies of the Kidney and Urinary Tract (CAKUT). (NCT04115345) | Prokidney | 2019-08-13 |
| Breaking Down Care Process and Patient-level Barriers to Arteriovenous Access Creation Prior to Hemodialysis Initiation (NCT04032613) | University of North Carolina, Chapel Hill | 2019-07-30 |
| A Study to Assess the Relative Bioavailability of 3 Different Formulations Under Fasted and Fed Condition (NCT04024501) | AstraZeneca | 2019-07-20 |
| Evaluation of Serum Klotho as a Predictor of Progression of Cardiovascular Calcification in Chronic Kidney Disease (NCT03996746) | Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | 2019-06-25 |
| H+ Mobilization With Dialysate Bicarbonate Variation (NCT04020757) | Tufts Medical Center | 2019-06-12 |
| Nitrite-boosting Therapy for Improving Physiological Function in Patients With Chronic Kidney Disease (NCT03826147) | University of Colorado, Boulder | 2019-05-01 |
| A Trial of Etelcalcetide in Pediatric Participants With Secondary Hyperparathyroidism and Chronic Kidney Disease on Hemodialysis (NCT03633708) | Amgen | 2019-04-29 |
| Alternations of Intestinal Microbiota and Health Impact in CKD (NCT03794401) | Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation | 2019-04-01 |
| A Study of RBT-9 in Healthy Volunteers and Volunteers With Stage 3/4 Chronic Kidney Disease (NCT04072861) | Renibus Therapeutics, Inc. | 2019-03-31 |
| Study to Assess PK, Safety and Tolerability in Patients With DM and CKD (NCT03795389) | DiaMedica Therapeutics Inc | 2019-02-12 |
| EMPA-KIDNEY (The Study of Heart and Kidney Protection With Empagliflozin) (NCT03594110) | Boehringer Ingelheim | 2019-01-31 |
| A Study to Assess the Safety and Pharmacokinetics of Verinurad and Allopurinol in Asian and Chinese Subjects (NCT03836599) | AstraZeneca | 2019-01-16 |
| Development and Validation of a Machine Learning Model for Differentiating Diabetic Kidney Disease and Non-Diabetic Kidney Disease in Type 2 Diabetes (NCT07672639) | Beijing Tongren Hospital | 2019-01-01 |
| Management of Cardiovascular Disease in Kidney Disease (MaCK) Study (NCT03636152) | VA Office of Research and Development | 2018-12-14 |
| Physical Rehabilitation and Chronic Kidney Disease (NCT03671343) | Hospices Civils de Lyon | 2018-12-01 |
| The Role of Isolated Nocturnal Hypertension Pattern in Nondialysis CKD (NCT03604003) | Fifth Affiliated Hospital, Sun Yat-Sen University | 2018-11-30 |
| Evaluation of Effect of TRC101 on Progression of Chronic Kidney Disease in Subjects With Metabolic Acidosis (NCT03710291) | Tricida, Inc. | 2018-11-20 |
| Trial of Nicotinamide Riboside and Co-enzyme Q10 in Chronic Kidney Disease (NCT03579693) | University of Washington | 2018-11-14 |
| Dental Intervention Plan for Chronic Kidney Disease Patients Awaiting or With Kidney Transplant (NCT04020458) | Augusta University | 2018-11-09 |
| A Study of RBT-3 in Healthy Volunteers and Volunteers With Stage 3/4 Chronic Kidney Disease (NCT04072432) | Renibus Therapeutics, Inc. | 2018-10-21 |
| Integrating Risk-based Care for Patients With CKD (NCT03365063) | University of Manitoba | 2018-08-24 |
| Biomarker for Patients With Fabry Disease (BioFabry) (NCT02778295) | CENTOGENE GmbH Rostock | 2018-08-20 |
| Home-based Exercise in Chronic Kidney Disease (NCT03621176) | Cardenal Herrera University | 2018-08-01 |
| Evaluation of Thyroid Function in Patients With Chronic Kidney Disease (NCT04658524) | Rio de Janeiro State University | 2018-07-01 |
| Clearance of 25-hydroxyvitamin D3 During Vitamin D3 Supplementation (NCT03576716) | University of Washington | 2018-06-01 |
| Nanshan Elderly Cohort Study (NCT03569735) | Sun Yat-sen University | 2018-05-26 |
| Head-to-Head Study of Etelcalcetide and Cinacalcet in Asian Hemodialysis Patients With Secondary Hyperparathyroidism (SHPT) (NCT03299244) | Amgen | 2018-05-15 |
| Tissue-nonspecific Alkaline Phosphatase in Phosphate and Pyrophosphate Homeostasis. (NCT03520738) | Centre Hospitalier Universitaire de Nice | 2018-05-15 |
| House Calls and Peer Mentorship (NCT03354910) | Beth Israel Deaconess Medical Center | 2018-04-30 |
| Stress and CKD Among African Americans (NCT03387319) | Emory University | 2018-04-27 |
| A Study of Autologous Renal Autologous Cell Therapy (REACT) in Patients With Diabetic Chronic Kidney Disease (NCT03270956) | Prokidney | 2018-04-25 |